Status:
UNKNOWN
Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han Population
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
CD163 is a member of the scavenger receptor cysteine-rich family (SRCR) is exclusively expressed on cells of the monocyte lineage.CD163 acts to amplify inflammation and serves as a critical mediator o...
Eligibility Criteria
Inclusion
- Sepsis met the criteria recommended by 1991 ACCP/SCCM Joint Meeting and by the diagnostic criteria developed at the 2001 International Sepsis Definition Conference.
Exclusion
- (1) younger than 18 years of age; (2) acquired immunodeficiency syndrome; (3) reduced polymorphonuclear granulocyte counts (\< 500 μL-1); (4) died within 24h after admission into the ICU, or refused to participate in the study, or declined treatment during the period of observation.
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2012
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01504243
Start Date
May 1 2010
End Date
May 1 2012
Last Update
January 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China